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Abstract. The potential role of systemic inflammation on 
brain injury in newborns with congenital heart disease (CHD) 
was assessed by measuring levels of central nervous system 
(CNS)-derived proteins in serum prior to and following 
cardiac surgery. A total of 23 newborns (gestational age, 
39±1 weeks) with a diagnosis of CHD that required cardiac 
surgery with cardiopulmonary bypass (CPB) were enrolled in 
the current study. Serum samples were collected immediately 
prior to surgery and 2, 24 and 48 h following CPB, and 
serum levels of phosphorylated neurofilament‑heavy subunit 
(pNF-H), neuron-specific enolase (NSE) and S100B were 
analyzed. Systemic inflammation was assessed by measuring 
serum concentrations of complement C5a and complement 
sC5b9, and the following cytokines: Interleukin (IL)-1β, IL-6, 
IL-8, IL-10, IL12p70, interferon γ and tumor necrosis factor 
(TNF)-α. Analysis of cord blood from normal term deliveries 
(n=26) provided surrogate normative values for newborns. 
pNF-H and S100B were 2.4- to 2.8-fold higher (P<0.0001) in 
patient sera than in cord blood prior to surgery and remained 
elevated following CPB. Pre-surgical serum pNF-H and 
S100B levels directly correlated with interleukin (IL)-12p70 
(ρ=0.442, P<0.05). pNF-H was inversely correlated with 
arterial pO2 prior to surgery (ρ=-0.493, P=0.01) and directly 
correlated with arterial pCO2 post-CPB (ρ=0.426, P<0.05), 
suggesting that tissue hypoxia and inflammation contribute 
to blood brain barrier (BBB) dysfunction and neuronal injury. 
Serum IL12p70, IL-6, IL-8, IL-10 and TNF-α levels were 
significantly higher in patients than in normal cord blood and 
levels of these cytokines increased following CPB (P<0.001). 
Activation of complement was observed in all patients prior 
to surgery, and serum C5a and sC5b9 remained elevated up to 
48 h post-surgery. Furthermore, they were correlated (P<0.05) 
with low arterial pO2, high pCO2 and elevated arterial pressure 
in the postoperative period. Length of mechanical ventilation 
was associated directly with post-surgery serum IL-12p70 and 
IL-8 concentrations (P<0.05). Elevated serum concentrations 
of pNF-H and S100B in neonates with CHD suggest BBB 
dysfunction and CNS injury, with concurrent hypoxemia and 
an activated inflammatory response potentiating this effect.
Introduction
Approximately 8 in 1,000 live births are diagnosed with a 
congenital heart defect (1) and many require surgical inter-
vention to ensure survival beyond the neonatal period. Recent 
advances in medical management, transcatheter interven-
tion, surgical procedures and cardiopulmonary bypass, have 
significantly increased the survival rate of such children. Up to 
50% of children with congenital heart disease (CHD) experi-
ence neurodevelopmental and behavioral problems including 
seizures, cognitive impairment, delays in speech, language, 
visual‑motor and visual‑spatial skills, attention deficit/hyper-
activity disorder and learning disabilities (2-5).
The etiology of the neurobehavioral problems in children 
with CHD is complex, with contributions of innate factors 
including genotype that cannot be modified and acquired 
factors that potentially may be (6). These acquired factors 
are secondary to chronic and acute hypoxia, hypoperfusion, 
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hematocrit, reperfusion injury, and surgery with cardio-
pulmonary bypass and cross-clamp, and have a cumulative 
effect (7,8). The developing fetus with congenital heart defects 
may be exposed to hypoxia and abnormal cerebral perfusion 
in utero and these insults on the brain may continue during 
the neonatal period as a result of the failing heart (9,10). The 
mechanisms of brain injury are poorly understood but may 
involve multiple causative factors including maternal infection, 
inflammation, hypoxia and hypoperfusion, as observed in the 
development of periventricular leukomalacia (PVL), charac-
terized by cerebral white matter damage (11-13). PVL has been 
documented by brain magnetic resonance imaging (MRI) in 
16% of children with congenital heart disease and this inci-
dence increases to 50% in children following cardiac surgery 
with cardiopulmonary bypass (CPB) (14). The duration of 
CPB, complexity of the anatomical defect and surgical repair, 
and the occurrence of cyanosis contribute to the postopera-
tive systemic inflammatory response. This involves activated 
complements and lymphocytes, monocytes/macrophages, 
endothelial cells and myocytes expressing cytokines, such as 
tumor necrosis factor (TNF)-α and interleukins (ILs) (15-20). 
Postoperative systemic inflammatory response syndrome is 
a complication occurring in pediatric patients, particularly 
neonates undergoing corrective or palliative heart surgery and 
remains a challenge during the postoperative management 
of these patients (21-25). Inflammation during early brain 
development has been implicated in white matter damage and 
has been associated with cerebral palsy, autism and neuropsy-
chological disorders (26-29). In experimental models, TNF-α 
induced myelin degeneration and oligodendrocyte apoptosis, 
and transgenic animals overexpressing TNF-α in the CNS 
exhibited demyelination and vacuolization (30,31). White 
matter injury is a complication of neonatal cardiac surgery and 
may occur in response to systemic inflammation; however, this 
association remains unclear and may be of relevance regarding 
patients undergoing highly complex cardiac surgeries (32,33).
The blood-brain and blood-cerebrospinal fluid (CSF) 
barriers restrict the passage of proteins into and out of the 
brain. Research on the blood-brain barrier (BBB) in experi-
mental models has demonstrated that prolonged systemic 
inflammation in the early post‑natal period leads to a transient 
increase in the permeability of blood vessels in the brain to 
serum proteins (34). Similar to that observed with ischemic or 
traumatic brain injury, it has been postulated that cardiopul-
monary bypass with concomitant inflammation and activation 
of complements can lead to loss of integrity of the BBB and 
blood-CSF barrier (35-38).
Previous studies have determined that there is an asso-
ciation between the severity of the inflammatory response 
to heart surgery and an increased need for medical interven-
tion or length of stay at hospitals (20,21,39-43). The current 
study hypothesized that newborns with CHD and in whom 
circulating pro-inflammatory mediators and complements 
were elevated, would have measureable concentrations of 
CNS-derived proteins, indicative of a compromised BBB 
and CNS injury. Serum markers of brain injury (43) include 
the high molecular weight (200 kDa) neurofilament protein 
(NF-H) that is abundant in neurons and concentrated in axons. 
The highly phosphorylated form of NF (pNF-H) is resistant to 
proteolysis and when released from damaged axons remains 
largely intact; thus, its presence in the blood is indicative 
of neuronal damage (44,45). Other biomarkers measured 
included a brain‑specific isoform of enolase known as neuron 
specific enolase (NSE) (46) and S100, a 20 kDa protein 
belonging to the S100/calmodulin/troponin C superfamily of 
calcium-binding proteins that forms heterodimers (S100A1B) 
and homodimers (S100BB) in CNS glial cells and peripheral 
Schwann cells (47,48).
Patients and methods
Patient demographics and diagnostic classif ications. 
The current prospective study conducted at the Cohen 
Children's Medical Center of New York at Northwell Health 
(Manhasset, NY, USA) was approved by the Northwell Health 
Institutional Review Board and conducted in accordance with 
the Declaration of Helsinki. Written informed consent was 
obtained from parents on admission of patients to the hospital. 
A total of 23 patients with congenital heart disease requiring 
surgical repair with cardiopulmonary bypass were enrolled 
in the present study between January 2009 and August 2010. 
Full patient demographics are listed in Table I. The lesions 
consisted of hypoplastic left heart syndrome (n=8), transposi-
tion of the great arteries (n=5), co-arctation of the aorta (n=3), 
tricuspid atresia/pulmonary atresia (n=1), truncus arteriosus 
communis (n=1), aortopulmonary window (n=1), endocardial 
cushion defect (n=1), ventricular septal defect (n=1), anomalous 
right pulmonary artery (n=1) and total anomalous pulmonary 
venous connection (n=1). Two patients harbored known 
chromosomal abnormalities, including one with DiGeorge 
syndrome (22q11 deletion). Criteria for exclusion were body 
weight <1,600 grams, patent ductus arteriosus ligations, heart 
surgery without CPB, newborns of mothers with autoimmune 
disease and suspected congenital or postnatal infections.
Surgery, anesthesia and postoperative care. The conduction 
of surgical procedures including cardiopulmonary bypass 
and anesthesia followed our institutional standard practices. 
Sixteen of the 23 patients underwent CPB with deep hypo-
thermic circulatory arrest with an average circulatory arrest 
time of 20±16 min. Eleven of these 16 patients were treated 
by ice cooling of the head. Twenty-one patients required blood 
pressure medication intra-operatively and all patients received 
methylprednisolone. Postoperative patient management in 
the pediatric intensive care unit (PICU) followed the stan-
dard institutional protocol. Decisions regarding the medical 
management of each patient were based on clinical assessment 
made by attending PICU physicians who were unaware of the 
study protocol and analysis.
Clinical data acquisition and sample collection. Patient 
clinical data were recorded, including pre-operative vari-
ables such as birth weight, gestational age, APGAR score at 
birth, head circumference, abnormal chromosomal findings, 
abnormal head ultrasound findings, need for respiratory 
support including intubation and fraction of inspired oxygen 
(FiO2) requirement, pre-operative systemic saturation, arte-
rial pO2 and pCO2, lowest pre-operative hematocrit, degree of 
acidosis, lactate levels, mean arterial pressures, urine output, 
presence of infection, presence of seizures, administration 
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of vaccines or Rhogam, need for blood transfusion, need of 
prostin infusion or inotropes, or balloon atrial septostomy. 
Intra-operative data were recorded, including weight and age 
at perfusion, length of cardiopulmonary bypass and aortic 
cross-clamp time, administration of intra-op steroids and 
degree of cooling. Postoperative variables were also measured 
and included presence of arrhythmia, medication including 
inotropes and diuretics, mean arterial blood pressure (MAP), 
degree of acidosis, blood lactate levels, hematocrit, pO2 and 
pCO2, FiO2 requirement, duration of mechanical ventilation, 
duration of PICU care and hospitalization, systemic oxygen 
saturation at discharge and any neurological findings such as 
seizures, neurodevelopmental risk evaluation score or brain 
imaging results. Brain imaging protocols included brain 
ultrasound, computed tomography, electroencephalogram 
(EEG) or MRI during routine postoperative care of the 
patient.
Blood samples from patients were drawn from central intra-
venous catheters preoperatively and 2, 24 and 48 h following 
CPB. Blood was allowed to clot at room temperature for 4 h 
and subsequently centrifuged at 1,000 x g for 15 min at room 
temperature. Serum was stored at ‑70˚C until analysis. Serum 
samples were also obtained from cord blood collected from 
26 healthy term births that were donated to the Tissue Donation 
Program of Northwell Health but which were not used for stem 
cell collection due to insufficient cell counts. Data from these 
samples were used as normative newborn values.
Analyses of serum samples. Commercially available ELISA 
or EIA kits were used to measure serum concentrations of 
pNF-H (cat. no. RD191138300R; BioVendor LLC, Asheville, 
NC, USA), human NSE (cat. no. 0050; Alpha Diagnostic 
International, San Antonio, TX, USA), S-100B (cat. no. 708-85; 
Fujirebio Diagnostics, Inc., Göteborg, Sweden), C5a and 
sC5b-9 (cat. no. A021 & A020; Quidel Corp., San Diego, CA, 
USA). The Meso Scale Discovery multiplex assay kit (cat. 
no. K15008C-2; MSD, Rockville, MD, USA) was used for 
simultaneous measurement of cytokines IL-6, IL-8, IL-12p70, 
IL-1β, TNF-α, interferon (INF)-γ, and IL-10 in each serum 
sample.
Immunoblot analysis. The specificity of the anti‑pNF‑H anti-
body used in the ELISA was verified via immunoblot analysis 
comparing mouse brain tissue with patient plasma samples. 
Murine brain lysate was prepared as previously described (49). 
For immunoblot analysis, serum samples (12 µl) from 
2 randomly selected patients were diluted in Laemmli buffer 
and separated by SDS-PAGE on 10% polyacrylamide gels, 
transferred to nitrocellulose membranes and incubated at 
4˚C overnight with monoclonal antibody against pNF‑H (cat 
no. IMG-5018A-2; 1:1,000; Novus Biologicals, LLC, Littleton, 
CO, USA). Signal from horseradish peroxidase-conjugated 
secondary antibody (cat. no. 170-6516; 1:5,000; Bio-Rad 
Laboratories, Inc., Hercules, CA, USA) was developed 
using chemiluminescence reagent (Western Lightning 
Electrochemiluminescence Pro; cat. no. NEL120001EA; 
Perkin-Elmer, Inc., Waltham, MA, USA) and detected by 
exposure to x‑ray film. A sample of murine brain lysate (20 µg 
protein) was used to positively identify the antibody reactive 
pNF-H protein band.
Statistical analysis. Comparisons among variables were made 
using one-way analysis of variance or Kruskal-Wallis test, as 
appropriate, for continuous-type measures and the χ2 or Fisher's 
exact test for categorical outcomes. Healthy controls were 
compared to patients using the Mann-Whitney test for contin-
uous measures and the χ2 or Fisher's exact test for categorical 
outcomes. Spearman correlations were calculated to determine 
the strength of correlation between serum biomarkers. A mixed 
models approach to repeated measures analysis of variance was 
conducted to determine if the patterns of change across time 
with respect to each of the biomarker levels differed between 
groups. Bonferroni-like adjusted pairwise comparisons 
(P<0.01) were used post-hoc to determine which time points 
differed from one another. Statistical analysis was performed 
using SAS V9.3 (SAS Institute Inc., Cary, NC, USA).
Results
Study patients and perioperative data. Table I lists patient 
demographics, mean (± standard deviation) and median values 
(min-max range) of specific pre-, intra- and postoperative 
physiological measures and outcome variables that were used 
for statistical analyses.
Role of cyanosis. A total of 70% (16/23) of patients were 
cyanotic prior to surgery, and they received surgery at a 
younger age compared with the seven acyanotic patients 
(5.9±3.2 vs. 11.4±6.4 days, respectively). The cyanotic patients 
had significantly longer bypass times (160±49 vs. 100±15 min; 
P=0.007) and total cross clamp times (75±38 vs. 40±17 min; 
P=0.012) indicative of greater complexity of surgical cardiac 
repair. When patients prior to surgery were grouped as 
cyanotic or acyanotic, no statistically significant differences 
in serum biomarkers either prior to or following surgery were 
measured. Therefore, data from all patients were combined for 
the statistical analyses presented herein.
Brain biomarkers prior to and following cardiopulmonary 
bypass surgery. The presence of pNF-H in the serum of 
newborns with CHD has not been previously reported. 
Therefore, the specificity of the detection antibody used 
in the ELISA assay was tested by immunoblot analysis of 
patient sera and mouse brain tissue known to express pNF-H. 
The antibody recognized both high- and medium-molecular 
weight NF proteins in mouse brain and a corresponding 
200 kDa protein in two patient serum samples, thus 
confirming its specificity (Fig. 1). pNF-H concentration in 
the pre-surgical samples of patients was 2.4-fold higher 
(P<0.0001) than that measured in cord blood from healthy 
term births (Table II). The concentration of pNF-H in serum 
obtained 2 h after CPB was significantly reduced compared 
with pre-surgery (P<0.0001) but then accumulated during the 
subsequent period, reaching pre-surgical levels 48 h following 
CPB (Fig. 2). S100B, a protein expressed in glial cells, was 
also significantly higher in patient sera prior to surgery 
compared with normal cord blood (P<0.00001; Table II) and 
increased significantly 2 h following CPB (P<0.0001), further 
supporting potential CNS injury in these patients (Fig. 2). 
Both the rapid increase of S100B following CPB and subse-
quent rapid decrease in 24 h likely reflects its reported short 
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half-life (~60 min). The amount of NSE in patient sera prior 
to surgery did not differ significantly from that in normal 
cord blood (Table II); however, it increased significantly 2 h 
post-CPB (P<0.0001) and then slowly decreased to pre-CPB 
levels over the subsequent 48 h, reflecting a longer reported 
serum half-life of ~30 h (Fig. 2).
Inf lammation in neonates and response to surgery. 
Concentrations of cytokines, apart from INF-γ and IL-1β, 
were significantly lower in normal cord blood than in the sera 
of patients prior to surgery (P<0.05) (Table II). The responses 
of these inflammatory mediators to surgery are presented in 
Fig. 3. Serum levels of all ILs and INF-γ peaked immediately 
following CPB (P<0.01) and then decreased over the following 
48 h (Fig. 3), although levels of IL-1β increased slightly but 
not significantly over 48 h post‑CPB (data not shown). Serum 
TNF-α levels remained unchanged throughout the pre- and 
postoperative periods (Fig. 3). Complement activation, 
specifically the serum level of soluble C5b9, which poten-
tially measures endothelial injury, was higher (P<0.0001) in 
patients prior to surgery than in normal cord blood (Table II). 
Serum C5a and sC5b9 concentrations increased progressively 
following surgery, with levels at 48 h being significantly higher 
than pre-surgical values (P<0.01; Fig. 4).
Table I. Patient demographics and peri-operative variables.
Variable Mean ± SD Median Min-max
All patients (n=23)
Male % (n) 48 (11)
Gestational age, weeks 39±1.4 39.4 35.2-41.0
Birth weight, kg 3.235±0.410 3.345 2.381-3.750
Age at surgery, days 7.6±5 6.0 3-20
Weight at surgery, kg 3.2±0.4 3.2 2.5-3.8
Body mass index, kg/m2 12.83±1.49 12.57 10.97-18.12
Pre-operative data
  SaO2 (%) 87±11 90 60-99
  Hb (g/dl) 12.5±2.5 12.3 8.6-18.0
  PaO2 (median value, mmHg) 48±29 40 25-154
  PaCO2 (highest value. mmHg) 50±22 45 30-142
  HCO3- (lowest value, mEq/l) 20.3±4.3 21.0 5-27
  pH 7.27±0.16 7.31 6.71-7.42
  Lactate (mg/dl) 5.3±4.3 3.7 1.4-21.0
  MAP (mmHg) 48±4 48 40-56
Intra-operative data
  Bypass time, min 141±49 139 44-240
  Cross-clamp time, min 71±32 72 21-14
Postoperative data (within 48 h)
  FiO2 requirement 0.48±0.18 0.50 0.21-1.00
  Hb (lowest value, g/dl) 11.3±1.7 11.0 8.3-15.3
  PaO2 (lowest value, mmHg) 74±37 64 29-160
  PaCO2 (median value, mmHg) 49±8 50 35-60
  pH 7.36±0.09 7.37 7.07-7.50
  Lactate (highest value, mg/dl) 8.0±6.6 6.0 1.9-25.0
  SaO2 at discharge % 90±10 96 66-100
  MAP (mmHg) 52±5 50 45-66
  Mechanical ventilation, days 10.0±15.9 5.0 1.0-69.0
  Intensive care unit stay, days 13.3±14.5 9.0 4.0-69.0
  Hospital stay, days 20.8±13.5 17.0 7.0-69.0
SD, standard deviation; Hb, hemoglobin; MAP, mean arterial blood pressure; FiO2, fraction of inspired oxygen.
Figure 1. Immunoblot analysis of pNF-H in patient sera and mouse brain 
tissue. Molecular weight is indicated as kilodaltons (kDa). NF-H, neuro-
filament heavy chain subunit; NF‑M, medium molecular weight subunit of 
neurofilament as identified in mouse brain.
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Correlation between brain‑derived biomarkers and inflam-
matory cytokines prior to surgery. The systemic inflammatory 
response to heart surgery with CPB in neonates has been well 
documented (15-21). However, immune function in neonates 
with CHD prior to heart surgery and its potential role on the 
clinical course of these patients is less clear. In the present 
study, Spearman correlation analysis demonstrated significant 
positive associations between the age of patients at surgery and 
pre-surgical serum levels of the cytokines (P<0.05; Table III). 
The age-dependent increases in serum IL-12p70, INF-γ 
TNF-α and IL-10 may be indicative of immune activation of T 
helper (Th) 1 immune response in these neonates. By contrast, 
the levels of the interleukins IL-1β, IL-6 and IL-8 were not 
correlated with patient age.
To support the hypothesis that inflammatory media-
tors serve a role in BBB permeability, it was observed that 
pre-surgical serum IL-12p70 concentrations correlated directly 
with levels of the brain proteins pNF-H and S100B (r=0.442, 
P<0.05; Fig. 5). Fig. 5 presents individual patient values for 
these biomarkers and a linear regression line drawn between 
serum pNF-H and IL-12p70.
It was examined whether pre-operative blood pressure 
and/or inotropic support of patients correlated with inflamma-
tory biomarkers. A total of 15 patients treated with diuretics 
had significantly higher serum TNF‑α, IL-10, IL12p70, IL1β 
and IL-6 levels compared with untreated patients (P<0.05; 
Table IV). Seven of these 15 patients also received dopamine 
and 8 patients (4 receiving both diuretics and dopamine) had 
elevated blood creatinine levels compared with the normal 
range for neonates (data not shown), suggesting that patients 
who were hemodynamically unstable exhibited an augmented 
inflammatory response. Furthermore, 12 patients requiring 
ventilator support had significantly lower serum concentrations 
of the anti‑inflammatory cytokine IL‑10, compared with those 
who were not mechanically ventilated (P<0.05; Table IV). Of 
the other pre-operative variables recorded, arterial blood pO2 
correlated inversely with serum pNF-H, suggesting a potential 
causal relationship between hypoxemia and increased CNS 
injury (Table V).
Postoperative outcomes and serum biomarkers. Postoperative 
outcome variables demonstrating statistically significant 
correlations with serum brain biomarkers, cytokines and 
Figure 2. Concentration of CNS biomarkers in patient sera taken immedi-
ately prior to surgery (pre-) and at 2, 24 and 48 h post-CPB. Scatter plot 
represents individual patient data. Box plot: box boundaries indicates 25th 
and 75th percentile; line marks the median; whiskers indicate 10th and 
90th percentiles. Statistical significance was determined by RM‑ANOVA 
followed by Bonferroni post-hoc analysis for pairwise comparisons. *P<0.01; 
**P<0.001; ***P<0.0001. CPB, NSE, neuron-specific enolase; S100B, B 
subunit of calcium‑binding protein S100; pNF‑H, phosphorylated neurofila-
ment heavy chain; repeated measures-ANOVA, analysis of variance; CPB, 
cardiac surgery with cardiopulmonary bypass.
Table II. Serum concentrations of cytokines and brain-derived 
biomarkers.
  CHD patients
 Normal cord blood pre-surgery
Serum biomarker Mean ± SD Mean ± SD 
(concentration) (n=20) (n=23)
pNF-H (pg/ml) 136.8±53.9 328.7±155.7d
S100B (pg/ml) 126.3±113.6 358.0±210.2d
NSE (ng/ml) 20.27±9.93 15.50±15.17
C5A (ng/ml) 5.62±4.40 12.87±8.40b
sC5B9 (ng/ml) 79.0±48.1 652.2±491.1d
INF-γ (pg/ml) 0.18±0.13 0.40±0.39
IL-10 (pg/ml) 0.85±0.41 6.61±7.03d
IL-12p70 (pg/ml) 0.15±0.26 0.59±1.38a
IL-1β (pg/ml) 0.66±1.12 1.70±3.86
IL-6 (pg/ml) 1.86±1.08 11.01±17.99c
IL-8 (pg/ml) 6.61±1.94 36.49±48.62d
TNF-α (pg/ml) 4.43±1.12 14.02±8.01d
Values are mean ± SD of samples from cord blood of healthy term 
births and from patients with CHD obtained prior to heart surgery. 
n=number of patients. aP<0.05; bP<0.01; cP<0.001; dP<0.00001 
vs. normal cord blood; TNF, tumor necrosis factor; IL, interleukin; 
INF, interferon; NSE, neuron specific enolase; CHD, congenital heart 
disease; SD, standard deviation.
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complements are presented in Table V. Correlations were 
determined between physiological measurements recorded 
during the first or second 24 h period post‑CPB and blood 
samples obtained at 24 or 48 h. MAP during the first 2 days 
post-CPB correlated positively with serum TNF-α and C5a. 
Measurements indicative of tissue hypoxia including arterial 
blood gases (pO2, pCO2) and lactate, and increased require-
ment for oxygen inhalation (FiO2) correlated significantly with 
inflammatory responses and complement activation. Levels of 
the brain biomarkers pNF-H and NSE correlated directly with 
blood pCO2 and lactate, respectively (both P<0.05) during 
the first 24 and 48 h post‑CPB, suggesting that hypoxia may 
have contributed to BBB permeability and release of these 
brain proteins. Serum levels of S100B and NSE, as well as 
IL-8 and IL-10, were inversely correlated with blood oxygen 
saturation at hospital discharge (P<0.01, P<0.05, P<0.01 and 
P<0.01, respectively) suggesting that systemic inflammation 
following surgery was an important determinant of clinical 
course (Table V). The postoperative duration of mechanical 
ventilation (length of intubation) was directly correlated with 
serum levels of IL-12p70 and IL-8 measured 48 h post-CPB 
(both P<0.05; Table V).
Although only a small number of patients (six) without 
chromosomal abnormalities exhibited anomalies in brain 
imaging during their hospital course, they had significantly 
higher serum levels of IL-12p70 (1.21±0.58 vs. 0.77±0.86 pg/ml, 
P<0.05) and NSE (50.64±32.19 vs. 23.52±20.86 ng/ml, P<0.05) 
Figure 3. Concentration of cytokines in patient sera taken immediately prior to surgery (pre-) and 2, 24 and 48 h post-CPB. Scatter plot represents individual 
patient data. Box plot: box boundaries indicates 25th and 75th percentile; line marks the median; whiskers indicate 10th and 90th percentiles. Statistical 
significance was determined by RM‑ANOVA followed by Bonferroni post‑hoc analysis for pairwise comparisons. *P<0.01; **P<0.001; ***P<0.0001. CPB, 
cardiac surgery with cardiopulmonary bypass; RM-ANOVA, analysis of variance; IL, interleukin; INF, interferon; TNF, tumor necrosis factor.
Figure 4. Concentration of complement in patient sera taken immediately 
prior to surgery and at 2, 24 and 48 h post-CPB. Scatter plot represents 
individual patient data. Box plot: box boundaries indicates 25th and 75th 
percentile; line marks the median; whiskers indicate 10th and 90th percen-
tiles. Statistical significance was determined by RM‑ANOVA followed by 
Bonferroni post-hoc analysis for pairwise comparisons. *P<0.01; ***P<0.0001. 
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following surgery compared with the 15 patients without any 
suspicion of CNS pathology or clinical findings.
Discussion
In the present study, it was hypothesized that newborns with 
CHD and specifically those with tissue hypoxia, experience 
systemic inflammation as a consequence of the disease, which 
results in dysfunction of the BBB and subsequent injury to the 
CNS as measured by the presence of circulating CNS-derived 
proteins. A number of studies have linked elevated levels of 
circulating pro‑inflammatory cytokines, including TNF‑α and 
IL-6 that are derived from peripheral immune cells or sites of 
organ/tissue injury, to BBB failure (50,51). Evidence suggests 
that brain microvascular endothelial cell damage may occur 
due to cytokine-induced reactive oxidative species produced 
by NADPH oxidases or by altered function of endothelial 
junction proteins (52,53) and that hypoxia-induced cytokine 
production may be an initiating event (54). Brain biomarkers, 
including pNF-H, S100B and NSE were detectable in patient 
serum prior to surgery and the concentrations of pNF-H and 
S100B were ~2.5-fold higher in patients than in normal cord 
blood. Both pNF-H and S100B levels were directly correlated 
with serum IL-12p70 and the correlation between pNF-H 
and IL‑8 trended towards significance. These data support 
a potential causal link between pro‑inflammatory mediators 
and BBB dysfunction with neuronal injury in these neonates. 
Furthermore, pre-operative arterial pO2 correlated inversely 
with serum pNF-H, while the strongest correlation with 
pre-operative arterial pCO2 was with TNF-α, suggesting that 
hypoxia and acidosis in neonatal patients with CHD may be 
an initiating event for the peripheral inflammatory response 
with a direct effect on CNS injury. This conclusion is further 
supported by results obtained from the 24-48 h postoperative 
period, during which serum pNF‑H correlated significantly 
with arterial pCO2, while NSE correlated directly with serum 
lactate. Furthermore, NSE and S100B were inversely associ-
ated with arterial oxygen saturation at discharge.
Modified ultrafiltration that allows for hemoconcentration 
and recovery of circuit blood following CPB, has been shown 
to remove certain inflammatory cytokines and components 
of the complement system from the circulation (55). Serum 
concentrations of IL-6, IL-10, TNF-α and C5b9 prior to and 
immediately following CPB in the present study are similar 
to those published in a study by Berdat et al (56) that demon-
strated that various ultrafiltration methods were effective at 
removing such mediators to a varying extent. Despite ultrafil-
tration, levels of the inflammatory mediators NSE and S100B, 
increased significantly immediately following CPB, reflecting 
their release/secretion and accumulation. Serum concentration 
of pNF-H, a large 200 kDa protein, decreased following CPB 
compared to pre-surgical levels, suggesting that it had been 
effectively removed by ultrafiltration. One explanation for these 
changes could be either volume expansion or hemoconcentra-
tion as a result of the CPB procedure. However, the results 
of the current study suggest that the temporal differences in 
serum concentrations of pNF-H, NSE and S100B possibly 
depended on their individual half-lives. The short half-life of 
S100B (90 min) predicted its rapid rise and fall immediately 
following CPB (<24 h), whereas the relatively longer half-life 
of NSE (~30 h) was reflected in its slower decline with serum 
concentrations at 24 h remaining significantly higher than 
pre-surgery. By contrast, the stable hyperphosphorylated 
NF-H protein with a half-life >3 days, was slow to rise in serum 
and took 48 h to reach concentrations similar to pre-surgery. 
Previous studies have demonstrated that pNF is elevated in 
serum for weeks following spinal cord or mild brain injury and 
in children with febrile seizures (45,57). Although the kinetics 
of these molecules in serum remain largely unknown, these 
data support the hypothesis that the BBB remains permeable 
in the initial h following CPB but begins to close within the 
first postoperative day. Abu‑Sultaneh et al (48) demonstrated 
a significant correlation between peak serum S100B following 
CPB with cerebral oxygen desaturation during surgery, as 
measured by near-infrared spectroscopy. Furthermore, it has 
been demonstrated that cerebral oxygen saturation is corre-
lated with neurodevelopmental outcomes and brain MRI at 
one year of age (58). While brain biomarkers, including S100B 
and NSE, have been studied in children in response to cardiac 
surgery with CPB, to the best of our knowledge this study isthe 
Table III. Correlations between serum biomarkers and patient 
age.
 TNF-α INF-γ IL-10 IL-12p70
Age at blood 0.500a 0.638c 0.491a 0.656c
draw/surgery
IL-12p70 0.544b 0.737d 0.576b -
IL-8 0.660c ns ns ns
sC5b9 0.450a ns ns ns
Correlations between biomarker concentrations in patient sera 
obtained immediately before surgery and patient age at surgery at the 
time of blood draw. Numbers are Spearman correlations ρ-values; 
aP<0.05; bP<0.01; cP<0.001; dP<0.0001. ns, not statistically signifi-
cant correlation; IL, interleukin; TNF tumor necrosis factor; INF, 
interferon.
Figure 5. Spearman correlation analysis between brain biomarkers, pNF-H, 
S100B and cytokine IL-12p70 in patient sera obtained prior to surgery 
demonstrated similar correlation coefficients of ρ=0.442 and P<0.05. The 
straight line represents the best‑fit linear regression between pNF‑H and 
IL-12p70. Triangles or circles represent individual patient serum S100B 
or pNF-H values, respectively, plotted vs. serum IL-12p70. IL, interleukin; 
pNF‑H, phosphorylated neurofilament‑heavy subunit.
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first to measure pNF‑H in the serum of newborns with CHD 
undergoing open-heart surgery with CPB.
Newborns with complex CHD have an increased risk of 
white matter injury, reduced brain growth and delayed brain 
development (6,59) and those requiring corrective surgeries 
with CPB during the neonatal period experience an inflam-
matory response (2,13,14,21,60,61). Although inflammation 
during the perinatal period has been determined to affect brain 
development in the pre-term infant (28,29), the significance of 
inflammation on the long‑term neurocognitive development of 
children with CHD who have undergone surgical cardiac repair 
remains unclear and its significance is controversial (7,33). Upon 
examination of various pre-operative treatments and postopera-
tive physiological outcome measurements, it was determined that 
patients receiving diuretics and/or dopamine had significantly 
higher serum concentrations of many cytokines, which cannot 
be explained solely by changes in intravascular/extracellular 
fluid volumes. In the postoperative period, levels of IL‑10 and 
IL-8 correlated with arterial hypoxemia and increased with 
blood lactate levels and inhaled O2 requirements. Other cyto-
kines, including TNF-α and IL-12p70, similarly correlated 
with these post-surgical parameters but with varying strengths 
of association. Thus, taken together these data support an 
augmented systemic inflammatory response to tissue hypoxia 
and acidosis, with an increased need for mechanical ventilation 
with higher oxygen requirements in the postoperative period, 
suggesting that these neonates may be at higher risk of CNS 
injury.
In light of reports that activation of complement leads 
to loss of integrity of the BBB and blood-CSF barrier, the 
Table IV. Effects of pre-operative treatments on serum cytokine concentrations. 
 Serum cytokines (pg/ml)
 ------------------------------------------------------------------------------------------------------------------------------------------------------------------
Treatment variables n TNF-α IL-10 IL-12p70 IL-1β IL-6
Ventilator support
  (+) 12 ns 3.72±2.88a ns ns ns
  (-) 10 ns 10.15±8.93 ns ns ns
Diuretics
  (+) 15 16.83±8.14a 8.73±7.93a 0.39±0.31a 1.60± 2.73a 14.84±21.58a
  (-)   8 8.41±3.60 2.99±2.65 0.11±0.10 0.30±0.22 4.09±4.82
Fisher's exact test for categorical outcomes was used to determine statistical differences between pre-operative treatment groups. aP<0.05; 
numbers are serum cytokine concentrations (pg/ml); ns, not statistically significant; TNF, tumor necrosis factor; IL, interleukin; n, number of 
patients/group; (+) treated, (-) not treated. 
Table V. Correlations between pre- or postoperative physiologic measurements and serum biomarkers.
 Serum brain biomarkers, complement, cytokines
 ---------------------------------------------------------------------------------------------------------------------------------------------------------------------
Variables pNF-H S100B NSE C5a sC5b9 TNF-α IL-10 IL-12p70 IL-8
PRE-OP
  pO2 (median value on ABG) -0.493a ns ns ns ns ns ns ns ns
  pCO2 (highest value on ABG) ns ns ns ns ns +0.448a ns ns ns
POSTOP
  MAP (median daily value) ns ns ns +0.551b ns +0.407a ns ns ns
  pO2 (lowest daily value ABG) ns ns ns ns -0.520b ns -0.437a ns -0.430a
  pCO2 (median daily value ABG) +0.426a ns ns +0.423a ns ns +0.449a ns ns
  Lactate (maximum daily value) ns ns +0.631a ns -0.500a ns +0.553b +0.727c +0.475a
  FiO2 requirement ns ns ns ns ns +0.425a +0.483a ns ns
O2 saturation at discharge ns -0.584b -0.489a ns +0.663c ns -0.611b ns -0.556b
Length of intubation ns ns ns ns ns ns ns +0.442a +0.445a
Correlations between physiological parameters measured pre‑operatively or during the first or second 24 h period post‑CPB and serum 
biomarkers measured in serum collected at those time points. Numbers are Spearman correlation ρ-values; aP<0.05; bP<0.01; cP<0.001. ABG, 
arterial blood gas; MAP, mean arterial pressure; FiO2, fraction of inspired oxygen; NSE, neuron specific enolase; IL, interleukin; TNF, tumor 
necrosis factor; ns, not statistically significant correlation.
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serum content of C5a was measured to assess activation of 
the complement system and serum sC5b-9 to assess potential 
cellular damage mediated by complement. Activation of the 
complement system has been observed in intracranial inflam-
mation following traumatic brain injury with upregulation of 
soluble terminal complement complex sC5b-9 in spinal cord 
fluid that correlated with degree of BBB dysfunction (36). C5a 
and C3a are known leukocyte chemotactic factors that can 
induce the release of lysosomal enzymes and oxygen-derived 
free radicals, and can stimulate cytokine production and 
release (62). In the present study, serum C5a and sC5b9 were 
significantly higher in patients who had red blood cell transfu-
sion prior to surgery and sC5b9 correlated directly with serum 
levels of TNF-α and IL-1β. In the postoperative period C5a and 
sC5b9 correlated with various parameters indicative of arte-
rial hypoxemia, elevated blood pressure and increased length 
of hospital stay. To the best of our knowledge, this is the first 
report demonstrating complement activation in this setting. 
Pagowska-Klimek et al (63) have recently reported that cardiac 
surgery with CPB activated the lectin pathway of comple-
ment activation and this response was significantly greater 
in pediatric patients presenting with post-bypass systemic 
inflammation. Further study is warranted in assessing the role 
of complement activation in brain injury in infants with CHD, 
particularly regarding novel therapeutic advances directed at 
the complement system to treat autoimmune diseases that may 
be repurposed for treatment of newborns with CHD (64-66).
It was observed that there was a significant correlation 
between patient age at surgery (between 3 and 20 days) and 
pre-surgical serum levels of TNF-α, IL-12p70, INF-γ and 
IL-10. The strongest correlation was between patient age at 
surgery and levels of IL-12 and INF-γ, which are Th1 cyto-
kines. Newborns exhibit a bias toward a Th2 cell-dominated 
cytokine response, including the release of IL-4, IL-6 and 
IL-10; however, with increasing age and maturation of dendritic 
cells and their production of IL-12 in response to INF-γ, a shift 
to a Th1 cell response occurs (67,68). The predominance of 
Th2 cytokine production in the fetus and neonate serves to 
dampen innate immune responses, protecting the newborn 
from Th1-induced affects (69,70). The capacity of mono-
nuclear cells to secrete a number of inflammatory cytokines 
increases with age from 2 months through one year to adult-
hood; however, monocytes from normal cord blood, which is 
essentially newborn blood, have increased capacity in response 
to pathogens to secrete TNF-α, IL-6, IL-10 and INF-γ (but 
not IL-12) at levels observed in adults (71,72). Similarly, the 
observation that serum concentrations of TNF-α, INF-γ and 
IL-12p70 increased in neonates as they lived longer with their 
disease prior to heart surgery suggests that the production 
of Th1 cytokines was in response to disease-induced effects 
rather than normal maturation of immunity towards Th1 cell 
polarization. Gestational age and weight have been reported to 
be important determinants of the neonate's immune response 
to infection (73). In the current study, mean gestational age 
was 39 weeks and no neonates were small for their gestational 
age, suggesting that these newborns had the capacity to elicit 
an age-appropriate innate immune response. Therefore, the 
current study concludes that term newborns with congenital 
heart disease may be able to elicit an age-appropriate immune 
response; however, this response to their disease process 
may promote an excessive pro‑inflammatory Th1 response 
potentially leading to end-organ damage, including increased 
permeability of the BBB and neuronal injury. New avenues 
of investigation, including studies examining the response of 
isolated peripheral blood mononuclear cells from neonates 
with CHD to various pathogenic and danger signals may 
advance understanding of innate immunity in this unique 
patient group and improve approaches to their medical care.
Limitations of the current study are the small sample size 
and absence of data from age-matched normal neonates aged 
between 3 and 30 days. Cord blood was analyzed from healthy 
term deliveries to provide surrogate normative newborn 
values. Although none of the study patients were small for 
gestational age or born pre-maturely, prospective collection of 
cord blood from these subjects would be preferable. A further 
limitation is the inclusion of congenital heart disease patholo-
gies with varying degrees of severity and complexity. Despite 
these limitations, consistent immune responses were observed 
in this patient population, lending support to the significance 
of the results.
In summary, the results of the present study demonstrate 
that neonates with congenital heart disease requiring surgical 
repair/palliation during the first month of life have elevated 
serum levels of pNF-H, a CNS-derived axonal protein that 
suggests brain injury with loss of BBB integrity. Concentrations 
of complement and pro‑inflammatory cytokines in the patients' 
serum were found to be higher than normal cord blood, and 
these biomarkers of inflammation were significantly corre-
lated with pre- and post-operative measurements of tissue 
hypoxia/acidosis, and an increased need for mechanical venti-
lation with higher oxygen requirements, suggesting that these 
neonates may be at higher risk of CNS injury.
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